Wise Young
Chief Science & Medical Advisor
Microbiology
Stemcyte
India
Biography
Dr. Wise Young is Distinguished Professor of Cell Biology & Neuroscience, Richard H. Shindell Chair in Neuroscience and Founding Director, W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey, is one of the world’s most outstanding neuroscientists and a foremost leader in spinal cord injury research. With a B.A. from Reed College, a Ph.D. from University of Iowa, an M.D. from Stanford University and a Surgery Internship at New York University (NYU) and Bellevue Medical Center, he became Director of Neurosurgery Research at NYU. He was a part of the team which discovered and established high-dose methypredisolone (MP) as the first effective therapy for spinal cord injuries. He has appeared as a guest on “20/20″, “48 Hours”, “Today”, “Eye to Eye”, Fox News and CNN. His work has been featured in a Life magazine special edition, in USA Today, and in numerous news, talk and print presentations worldwide. His honors to name a few include: NIH Jacob Javits Neuroscience Award (1985-1992), Wakeman Award (1991), Tall Texan of the Year Award (1997), “Cure” Award (1998), Trustees Award for Excellence in Research (2001), 2002 Asian American Achievement Award, Douglass Medal for work with the advancement of young women in the sciences (2003), and Elizabeth M. Boggs Award for service to the disability community (2004).the Recent award includes Everfront Award for Stem Cells and Cancer Research (Taipei, Taiwan) (2013); BioNJ Patient Advocacy Award (New Brunswick, NJ) (2014). In August 2001, TIME Magazine named Dr. Young as ‘America’s Best’ in the field of spinal cord injury research.• In 2005 he was the first researcher elected to the Spinal Cord Injury Hall of Fame. In 2006, Dr. Young received The Hope Award – A Salute to Research Innovation, the New Jersey Educator of the Year Award, and the Caring Heart Award. When the Richard H. Shindell Chair in Neuroscience was established at Rutgers University in 2006, Dr. Young was named as the first person to hold that chair.•In 2007 the Motolinsky Foundation named Wise Young as the recipient of their Distinguished Citizen Award. Dr. Young also serves as Chairman of the Advanced Therapeutics and Clinical Studies Committee. Current Advisory Positions and Board Memberships 2007-now: Board of Directors, Hong Kong Spinal Cord Injury Fund (Hong Kong). 2011-now: Global Medical Director, Stemcyte, International Inc;. 2013-now: Board of Directors, Stemcyte India. 2011-now: Scientific Advisor, Acorda Therapeutics, Hawthorne, NY.
Research Interest
Dr. Wise Young is Distinguished Professor of Cell Biology & Neuroscience, Richard H. Shindell Chair in Neuroscience and Founding Director, W.M. Keck Center for Collaborative Neuroscience at Rutgers, The State University of New Jersey, is one of the world’s most outstanding neuroscientists and a foremost leader in spinal cord injury research. With a B.A. from Reed College, a Ph.D. from University of Iowa, an M.D. from Stanford University and a Surgery Internship at New York University (NYU) and Bellevue Medical Center, he became Director of Neurosurgery Research at NYU. He was a part of the team which discovered and established high-dose methypredisolone (MP) as the first effective therapy for spinal cord injuries. He has appeared as a guest on “20/20″, “48 Hours”, “Today”, “Eye to Eye”, Fox News and CNN. His work has been featured in a Life magazine special edition, in USA Today, and in numerous news, talk and print presentations worldwide. His honors to name a few include: NIH Jacob Javits Neuroscience Award (1985-1992), Wakeman Award (1991), Tall Texan of the Year Award (1997), “Cure” Award (1998), Trustees Award for Excellence in Research (2001), 2002 Asian American Achievement Award, Douglass Medal for work with the advancement of young women in the sciences (2003), and Elizabeth M. Boggs Award for service to the disability community (2004).the Recent award includes Everfront Award for Stem Cells and Cancer Research (Taipei, Taiwan) (2013); BioNJ Patient Advocacy Award (New Brunswick, NJ) (2014). In August 2001, TIME Magazine named Dr. Young as ‘America’s Best’ in the field of spinal cord injury research.• In 2005 he was the first researcher elected to the Spinal Cord Injury Hall of Fame. In 2006, Dr. Young received The Hope Award – A Salute to Research Innovation, the New Jersey Educator of the Year Award, and the Caring Heart Award. When the Richard H. Shindell Chair in Neuroscience was established at Rutgers University in 2006, Dr. Young was named as the first person to hold that chair.•In 2007 the Motolinsky Foundation named Wise Young as the recipient of their Distinguished Citizen Award. Dr. Young also serves as Chairman of the Advanced Therapeutics and Clinical Studies Committee. Current Advisory Positions and Board Memberships 2007-now: Board of Directors, Hong Kong Spinal Cord Injury Fund (Hong Kong). 2011-now: Global Medical Director, Stemcyte, International Inc;. 2013-now: Board of Directors, Stemcyte India. 2011-now: Scientific Advisor, Acorda Therapeutics, Hawthorne, NY.
